Denmark· DK-28106416220
Jemperli
A dostarlimab product containing dostarlimab, registered in Denmark by Glaxosmithkline Trading Services Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Dostarlimab is registered in 12 of 19 countries.
Countries holding a registration under ATC L01FF07 (dostarlimab), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Dostarlimab · ATC L01FF07
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Dostarlimab
- Manufacturer
- Glaxosmithkline Trading Services Limited
- Country
- Denmark (DK)
- ATC code
- L01FF07
- ATC class
- Dostarlimab
- Defined daily dose
- 24 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106416220
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01FF07
Dostarlimab, as other registers publish it.
- NorwayJemperliGlaxoSmithKline Trading Services Limited
- United StatesJemperliGlaxoSmithKline LLC
- SwitzerlandJemperli
- IcelandJemperliGlaxoSmithKline Trading Services Limited
- PolandJemperliGlaxoSmithKline (Ireland) Limited
- FinlandJEMPERLIGlaxoSmithKline Trading Services Limited
- FinlandJEMPERLIOrifarm Oy
- FinlandJEMPERLIAbacus Medicine A/S
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7a034e9-325e-4e69-a498-0eca4666a9b0 GET /v1/drugs/d7a034e9-325e-4e69-a498-0eca4666a9b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "500 mg",
"auth_role": "CO-RAP",
"dk_drugid": "28106416220",
"substance": "Dostarlimab",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "44307"
}See everything about dostarlimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.